Epidemiology and identification of potential fungal pathogens causing invasive fungal infections in a tertiary care hospital in northeast Thailand.

Invasive fungal infections (IFIs) are life threatening and associated with a high mortality rate. Here, we describe the distribution of pathogens, host risk factors, and significance of fungi isolated from patients with IFIs. The study included 861 fungal isolates recovered between 2006 and 2011 from 802 patients at Srinagarind Hospital, Thailand. Based on the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group 2008 criteria, 28.5% (245/861 isolates) of the fungal isolates were considered to be causative agents of IFIs. The most common fungus was Candida albicans (46%, 396/861 isolates). However, the most common yeast causing IFIs was Cryptococcus neoformans (34.7%, 85/245 isolates), while the most common mould was Penicillium marneffei (10.6%, 26/245 isolates). Cryptococcosis was significantly associated with human immunodeficiency virus infections (P < 0.001). Trend analysis revealed that there was no significant increase in IFI cases (P = 0.34) from 2006 to 2011 or from 2007 to 2011 (P = 0.05), but there was a trend toward significant increases in candidiasis (P = 0.04). The fungal isolates were categorized according to the positive predictive value of their recovery in cultures as being true (>95%), moderate (5%-95%), and rare (<5%) pathogens. This classification system could facilitate the prediction of the likelihood of diseases caused by the isolated fungi.

[1]  Kinley Wangdi,et al.  Global evidence directing regional preventive strategies in Southeast Asia for fighting TB/HIV. , 2013, Journal of infection in developing countries.

[2]  M. Zheng,et al.  Invasive fungal infection in patients with systemic lupus erythematosus: experience from a single institute of Northern China. , 2012, Gene.

[3]  M. Orloff,et al.  Invasive fungal infections following liver transplantation: Incidence, risk factors, survival, and impact of fluconazole‐resistant Candida parapsilosis (2003‐2007) , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  T. Nemoto,et al.  Trends in the prevalence of invasive fungal infections from an analysis of annual records of autopsy cases of Toho University , 2012, Mycoses.

[5]  M. Hoenigl,et al.  European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. , 2012, The Journal of antimicrobial chemotherapy.

[6]  H. Schønheyder,et al.  National Surveillance of Fungemia in Denmark 2010-11 , 2012 .

[7]  J. Guinea,et al.  Epidemiology and Antifungal Susceptibility of Bloodstream Fungal Isolates in Pediatric Patients: a Spanish Multicenter Prospective Survey , 2011, Journal of Clinical Microbiology.

[8]  T.-H. Wu,et al.  Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000–2009 , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[9]  S. Uppin,et al.  Fungal infections as a contributing cause of death: an autopsy study. , 2011, Indian journal of pathology & microbiology.

[10]  H. Schønheyder,et al.  National Surveillance of Fungemia in Denmark (2004 to 2009) , 2010, Journal of Clinical Microbiology.

[11]  F. Queiroz-Telles,et al.  Epidemiology of opportunistic fungal infections in Latin America. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  N. Lee,et al.  A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan , 2010, Lupus.

[13]  Giuseppe Leone,et al.  Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study , 2010, Haematologica.

[14]  V. Preedy,et al.  European Organization for Research and Treatment of Cancer , 2010 .

[15]  K. Engels,et al.  Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. , 2010, The Journal of infection.

[16]  C. Napoli,et al.  Rare mycoses of the oral cavity: a literature epidemiologic review. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[17]  S. Antinori,et al.  Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. , 2009, American journal of clinical pathology.

[18]  Sung-Hwan Park,et al.  Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea , 2009, Lupus.

[19]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  T. Chirachariyavej,et al.  Invasive fungal infection in Ramathibodi Hospital: a ten-year autopsy review. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[21]  L. Pagano,et al.  Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  T. Sirisanthana,et al.  Penicillium marneffei Infection and Recent Advances in the Epidemiology and Molecular Biology Aspects , 2006, Clinical Microbiology Reviews.

[23]  D. Kontoyiannis,et al.  Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). , 2006, Haematologica.

[24]  M. Mungthin,et al.  Genetic diversity of Pneumocystis jirovecii in Thailand. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[25]  M. Richardson,et al.  Changing patterns and trends in systemic fungal infections. , 2005, The Journal of antimicrobial chemotherapy.

[26]  D. Bruckner,et al.  Frequency of Fungemia in Hospitalized Pediatric Inpatients Over 11 Years at a Tertiary Care Institution , 2005, Pediatrics.

[27]  M. Diaz,et al.  Invasive fungal infections in Chile: a multicenter study of fungal prevalence and susceptibility during a 1-year period. , 2004, Medical mycology.

[28]  S. Koch,et al.  Incidence of systemic mycoses in autopsy material , 2004, Mycoses.

[29]  D. Kontoyiannis,et al.  The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer , 2004, Cancer.

[30]  T. Peláez,et al.  The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis1 , 2003, Transplantation.

[31]  E. Bow,et al.  Antifungal prophylaxis for severely neutropenic chemotherapy recipients , 2002, Cancer.

[32]  J. Perfect,et al.  SAFETY OF AEROSOLIZED AMPHOTERICIN B LIPID COMPLEX IN LUNG TRANSPLANT RECIPIENTS12 , 2001, Transplantation.

[33]  P. Grossi,et al.  Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. , 2000, Transplantation.

[34]  A. Groll,et al.  Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. , 1996, The Journal of infection.